RAVE NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Rave Restaurant Group Inc · Consumer Cyclical · Restaurants

Open interactive chart View report data
Latest close 3.14 USD
-0.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 5.3% above the Trend Line and sits at 59.3% of its 52-week range. The latest completed week returned -0.3%, after a -4.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 33/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 42d.

Setup score 36 out of 100
Latest Close 3.14 USD 7 Aug 2026
1W Return -0.3% latest completed week
4W Return -4.6% short-term follow-through
12W Return 19.8% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 40.87% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.3% Latest completed week; four-week move -4.6%. Indicator stack 38/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.87% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 33/100 conviction; expected move 13.3%. News sentiment 52/100 43 relevant articles in the latest sentiment read. Event risk 42d Next report is scheduled for 24 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 5.3% above the Trend Line and sits at 59.3% of its 52-week range. The latest completed week returned -0.3%, after a -4.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6912-week average 0.43

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.69Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.6% over four weeks, 19.8% over 12 weeks, and 11.3% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W-0.3%
4W-4.6%
12W19.8%
26W-3.4%
52W11.3%
Active trend streak4 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.35Latest activity-pressure read.
Pressure change-59.6%Four-week change in activity pressure.
Leadership-9.18Latest relative-leadership reading.
RS change-55.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 91%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength42/100Blend of value, momentum, and quality. Underlying universe rank 59; rank 1 is best.
Value46/100Relative valuation strength. Underlying universe rank 55; rank 1 is best.
Quality44/100Profitability and accounting quality. Underlying universe rank 57; rank 1 is best.
Momentum46/100Medium-term price momentum. Underlying universe rank 55; rank 1 is best.
Growth46/100Revenue and earnings growth. Underlying universe rank 55; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework75/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
15.2x
Price divided by trailing earnings.
Price / sales
3.5x
Market value relative to trailing revenue.
EV / EBITDA
10.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
73.0%
Gross profit retained from each unit of revenue.
Operating margin
30.7%
Operating profit retained from revenue.
Free-cash-flow margin
26.5%
Free cash flow generated from revenue.
Return on invested capital
18.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
3.2%
Latest one-year revenue growth.
EPS growth
7.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-7.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.7%
Net share repurchases relative to market value.
Shareholder yield
2.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

RAVE shows mixed options pressure with a 33/100 conviction score, put-call volume ratio of n/a, expected move of 13.3%, and Sharemaestro trend signal active.

Conviction33/100
Expected move13.3%
Put/call volume
Pressure3
Speculation0
Volatility96
Trend agreement83
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 43 relevant articles.

8 positive · 30 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings42dNext report is scheduled for 24 Sep 2026; event risk rises as the date approaches.
Options expected move13.3%Nearest-chain priced movement where available.
52-week drawdown-16.3%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2614 weeks finished lower.
Best week+18.5%Week of 12 Jun.
Worst week-7.8%Week of 13 Mar.
Latest week-0.3%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks1
Modest losses6
Sharp losses8
Recent vol6.7%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split22/28Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape34/100

Trend, activity pressure, participation, and risk combine to a 34/100 tape read.

 Indicator analysis46/100

Latest 12-week confirmation: trend 4/12, activity pressure 11/12, relative leadership 1/12.

Activity pressure 0.69; 2 reversal markers Next-Week ExpectancyNegative 40.87%

Next-week expectancy is negative with a 40.87% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors43/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 19 SVQF75/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 179.5 of 718 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options55/100

RAVE shows mixed options pressure with a 33/100 conviction score, put-call volume ratio of n/a, expected move of 13.3%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 13.3% Sentiment52/100

Weighted news tone is neutral across 43 relevant articles.

Rave Restaurant Group Inc (RAVE) Financial Health: Profitability & Balance Sheet Analysis Insiders50/100

No recent insider transaction evidence is stored.

 Earnings42d

Next report is scheduled for 24 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20263.14 USD-0.3%2.98 USD2.54 USD0.35-9.18143.2KOn
31 Jul 20263.15 USD0.6%2.98 USD2.54 USD0.53-4.47154.9KOn
24 Jul 20263.13 USD-5.2%2.98 USD2.53 USD0.67-4.77132.4KOn
17 Jul 20263.30 USD0.3%2.99 USD2.53 USD0.81-1.4883.7KOn
10 Jul 20263.29 USD-3.5%2.97 USD2.52 USD0.88-5.91493.5KOff
3 Jul 20263.41 USD-0.3%2.96 USD2.51 USD0.91-0.92102.6KOff
26 Jun 20263.42 USD1.8%2.94 USD2.50 USD0.790.07201.4KOff
19 Jun 20263.36 USD-1.2%2.93 USD2.49 USD0.83-6.10195.0KOff
12 Jun 20263.40 USD18.5%2.92 USD2.48 USD0.69-2.56225.7KOff
5 Jun 20262.87 USD-5.6%2.91 USD2.47 USD0.43-15.83136.4KOff
29 May 20263.04 USD5.2%2.91 USD2.47 USD0.26-15.181.0MOff
22 May 20262.89 USD10.3%2.89 USD2.46 USD-0.13-17.43498.2KOff
15 May 20262.62 USD-6.4%2.88 USD2.45 USD-0.29-24.67915.0KOff
8 May 20262.80 USD1.8%2.88 USD2.44 USD-0.43-20.24203.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context